Mannkind (MNKD) Cash from Investing Activities (2010 - 2026)
Mannkind (MNKD) reported Cash from Investing Activities of $18.7 million for Q1 2026, up 214.07% year-over-year from $6.0 million in Q1 2025, and up 106.41% on a QoQ basis from -$292.0 million in Q4 2025.
Mannkind (MNKD) has 17 years of Cash from Investing Activities data on file, last reported at $18.7 million in Q1 2026.
- Quarterly Cash from Investing Activities rose 214.07% year-over-year to $18.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$292.0 million (down 591.22% YoY) and the FY2025 annual result came in at -$304.8 million, down 215.37% from the prior year.
- Cash from Investing Activities climbed to $18.7 million in Q1 2026 per MNKD's latest filing, from -$292.0 million in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $48.2 million in Q4 2024 and bottomed at -$292.0 million in Q4 2025.
- The 5-year median for Cash from Investing Activities is $2.0 million (2022), against an average of -$22.3 million.
- Peak annual rise in Cash from Investing Activities reached 710.82% in 2024, while the deepest fall reached 1606.0% in 2024.
- Tracing MNKD's Cash from Investing Activities over 5 years: stood at $15.0 million in 2022, then plunged by 152.6% to -$7.9 million in 2023, then surged by 710.82% to $48.2 million in 2024, then tumbled by 705.43% to -$292.0 million in 2025, then soared by 106.41% to $18.7 million in 2026.
- Per Business Quant, the three latest MNKD Cash from Investing Activities figures stand at $18.7 million (Q1 2026), -$292.0 million (Q4 2025), and -$25.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.89 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 638.50 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -431.90 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -428.90 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -25.54 Mn |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn | 18.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.73 Mn |
| Mar 31, 2026 | 18.73 Mn |
| Dec 31, 2025 | -291.96 Mn |
| Dec 31, 2025 | -291.96 Mn |
| Sep 30, 2025 | -25.06 Mn |
| Sep 30, 2025 | -25.06 Mn |
| Jun 30, 2025 | 6.26 Mn |
| Jun 30, 2025 | 6.26 Mn |
| Mar 31, 2025 | 5.96 Mn |
| Mar 31, 2025 | 5.96 Mn |
| Dec 31, 2024 | 48.22 Mn |
| Dec 31, 2024 | 48.22 Mn |
| Sep 30, 2024 | -41.26 Mn |
| Sep 30, 2024 | -41.26 Mn |
| Jun 30, 2024 | -55.18 Mn |
| Jun 30, 2024 | -55.18 Mn |
| Mar 31, 2024 | -48.44 Mn |
| Mar 31, 2024 | -48.44 Mn |
| Dec 31, 2023 | -7.90 Mn |
| Dec 31, 2023 | -7.90 Mn |
| Sep 30, 2023 | -11.55 Mn |
| Sep 30, 2023 | -11.55 Mn |
| Jun 30, 2023 | 3.66 Mn |
| Jun 30, 2023 | 3.66 Mn |
| Mar 31, 2023 | 13.79 Mn |
| Mar 31, 2023 | 13.79 Mn |
| Dec 31, 2022 | 15.01 Mn |
| Dec 31, 2022 | 15.01 Mn |
| Sep 30, 2022 | 27.35 Mn |
| Sep 30, 2022 | 27.35 Mn |
| Jun 30, 2022 | 2.02 Mn |
| Jun 30, 2022 | 2.02 Mn |
| Mar 31, 2022 | -39.51 Mn |
| Mar 31, 2022 | -39.51 Mn |
| Dec 31, 2021 | -12.58 Mn |
| Dec 31, 2021 | -12.58 Mn |
| Sep 30, 2021 | 4.99 Mn |
| Sep 30, 2021 | 4.99 Mn |
| Jun 30, 2021 | -112.53 Mn |
| Jun 30, 2021 | -112.53 Mn |
| Mar 31, 2021 | -31.42 Mn |
| Mar 31, 2021 | -31.42 Mn |
| Dec 31, 2020 | -4.48 Mn |
| Dec 31, 2020 | -4.48 Mn |
| Sep 30, 2020 | -4,000.00 |
| Sep 30, 2020 | -4,000.00 |
| Jun 30, 2020 | -150,000.00 |
| Jun 30, 2020 | -150,000.00 |
| Mar 31, 2020 | 19.85 Mn |
| Mar 31, 2020 | 19.85 Mn |
| Dec 31, 2019 | -202,000.00 |
| Dec 31, 2019 | -202,000.00 |
| Sep 30, 2019 | 3.76 Mn |
| Sep 30, 2019 | 3.76 Mn |
| Jun 30, 2019 | -1.37 Mn |
| Jun 30, 2019 | -1.37 Mn |
| Mar 31, 2019 | -25.03 Mn |
| Mar 31, 2019 | -25.03 Mn |
| Dec 31, 2018 | -244,000.00 |
| Dec 31, 2018 | -244,000.00 |
| Jun 30, 2017 | 24,000.00 |
| Jun 30, 2017 | 24,000.00 |
| Mar 31, 2017 | 16.65 Mn |
| Mar 31, 2017 | 16.65 Mn |
| Mar 31, 2016 | -1.13 Mn |
| Mar 31, 2016 | -1.13 Mn |
| Dec 31, 2015 | -312,000.00 |
| Dec 31, 2015 | -312,000.00 |
| Sep 30, 2015 | -1.15 Mn |
| Sep 30, 2015 | -1.15 Mn |
| Jun 30, 2015 | -4.53 Mn |
| Jun 30, 2015 | -4.53 Mn |
| Mar 31, 2015 | -4.20 Mn |
| Mar 31, 2015 | -4.20 Mn |
| Dec 31, 2014 | -14.21 Mn |
| Dec 31, 2014 | -14.21 Mn |
| Sep 30, 2014 | -217,000.00 |
| Sep 30, 2014 | -217,000.00 |
| Jun 30, 2014 | -8.26 Mn |
| Jun 30, 2014 | -8.26 Mn |
| Mar 31, 2014 | -1.41 Mn |
| Mar 31, 2014 | -1.41 Mn |
| Dec 31, 2013 | -6.17 Mn |
| Dec 31, 2013 | -6.17 Mn |
| Sep 30, 2013 | -230,000.00 |
| Sep 30, 2013 | -230,000.00 |
| Jun 30, 2013 | -132,000.00 |
| Jun 30, 2013 | -132,000.00 |
| Mar 31, 2013 | -1.46 Mn |
| Mar 31, 2013 | -1.46 Mn |
| Dec 31, 2012 | -61,000.00 |
| Dec 31, 2012 | -61,000.00 |
| Sep 30, 2012 | -124,000.00 |
| Sep 30, 2012 | -124,000.00 |
| Jun 30, 2012 | -84,000.00 |
| Jun 30, 2012 | -84,000.00 |
| Mar 31, 2012 | -291,000.00 |
| Mar 31, 2012 | -291,000.00 |
| Dec 31, 2011 | -125,000.00 |
| Dec 31, 2011 | -125,000.00 |
| Sep 30, 2011 | -594,000.00 |
| Sep 30, 2011 | -594,000.00 |
| Jun 30, 2011 | -4.05 Mn |
| Jun 30, 2011 | -4.05 Mn |
| Mar 31, 2011 | 1.84 Mn |
| Mar 31, 2011 | 1.84 Mn |
| Dec 31, 2010 | -8.11 Mn |
| Dec 31, 2010 | -8.11 Mn |
| Sep 30, 2010 | 445,000.00 |
| Sep 30, 2010 | 445,000.00 |